Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD) - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Journal Articles Microorganisms Year : 2021

Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD)

Abstract

Non-alcoholic fatty liver diseases (NAFLD) are associated with changes in the composition and metabolic activities of the gut microbiota. However, the causal role played by the gut microbiota in individual susceptibility to NAFLD and particularly at its early stage is still unclear. In this context, we transplanted the microbiota from a patient with fatty liver (NAFL) and from a healthy individual to two groups of mice. We first showed that the microbiota composition in recipient mice resembled the microbiota composition of their respective human donor. Following administration of a high-fructose, high-fat diet, mice that received the human NAFL microbiota (NAFLR) gained more weight and had a higher liver triglycerides level and higher plasma LDL cholesterol than mice that received the human healthy microbiota (HR). Metabolomic analyses revealed that it was associated with lower and higher plasma levels of glycine and 3Indolepropionic acid in NAFLR mice, respectively. Moreover, several bacterial genera and OTUs were identified as differently represented in the NAFLR and HR microbiota and therefore potentially responsible for the different phenotypes observed. Altogether, our results confirm that the gut bacteria play a role in obesity and steatosis development and that targeting the gut microbiota may be a preventive or therapeutic strategy in NAFLD management.
Fichier principal
Vignette du fichier
microorganisms-09-00199-v2.pdf (5.73 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03123187 , version 1 (13-02-2024)

Licence

Identifiers

Cite

Sebastian D Burz, Magali Monnoye, Catherine Philippe, William Farin, Vlad Ratziu, et al.. Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD). Microorganisms, 2021, 9 (1), pp. 199. ⟨10.3390/microorganisms9010199⟩. ⟨hal-03123187⟩
131 View
15 Download

Altmetric

Share

More